Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00379418 · ClinicalTrials.gov registry record
Anti Ischemic Effects of Abciximab in Angioplasty and Stenting Patients
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 220
- Enrollment target
NCT00379418: Completed study, sponsored by Emory University.
NCT00379418 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 220 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00379418 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 220 participants
- Enrollment target
Study Summary
AIR STUDY TITLE: Anti-Ischemic effects of Abciximab(Reopro) PATIENT POPULATION: Patients undergoing PCI(an interventional procedure placing a small stent/metallic tube to keep a narrowed artery in your heart open) and either on a stable statin dose or not on a statin. Statin= cholesterol lowering drug(ie, lipitor, zocor). INTERVENTION: Heparin vs. heparin + abciximab during PCI PURPOSE: Measure the effects of abciximab on special healing blood stem cells (EPC's-Endothelial Progenitor Cells), on inflammation, on oxidative stress and on microvascular blood flow. PATIENT ASSESSMENT: 1. 50ccs blood draw on day 1(from sheath), day 2 ,day 7 and day 28. 2. Measurement of blood flow in selected suitable patients 3. 10 minute questionnaire before discharge and on visit on day 28.
Interventions
- DRUG Abciximab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2003-01 |
| Est. Completion | 2009-12 |
What the finished NCT00379418 record still lists
NCT00379418 is an observational study that tracks outcomes without assigning an intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Abciximab is the first listed.
NCT00379418 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00379418 about?
NCT00379418 is a clinical study titled "Anti Ischemic Effects of Abciximab in Angioplasty and Stenting Patients". AIR STUDY TITLE: Anti-Ischemic effects of Abciximab(Reopro) PATIENT POPULATION: Patients undergoing PCI(an interventional procedure placing a small stent/metallic tube to keep a narrowed artery in your heart open) and either on a stable statin dose or not on a statin. Statin= cholesterol lowering ...
What is the current status of trial NCT00379418?
This trial is currently completed. The enrollment target is 220 participants. The study started on 2003-01. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00379418?
The interventions under investigation include: Abciximab (DRUG).
Who is sponsoring clinical trial NCT00379418?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00920972 · 220 participants · Phase 1
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
- NCT01851642 · 220 participants
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
- NCT02582021 · 220 participants
WISE CVD - Continuation (WISE HFpEF)
- NCT04067830 · 220 participants · Phase 2
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia